Lineage to Present at the B. Riley Securities’ Neuroscience Conference on April 28, 2021

by Business Wire • 2021/04/26 • 0 Comments

CARLSBAD, Calif.--(BUSINESS WIRE)---- $LCTX #LineageCell--Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today announced that Brian M. Culley, Chief Executive Officer, will be presenting at the B. Riley Securities’ Neuroscience Conference in a virtual fireside chat hosted by B. Riley Equity Research on Wednesday, April 28, 2021 at 1:30 p.m. ET. Interested investors can access the live and archived web

← Resumen: El CHMP recomienda la aprobación en la UE de Enspryng (satralizumab) de Chugai para el trastorno del espectro de la neuromielitis óptica (TENMO)

Glaukos, Intratus add presbyopia indication to licensing agreement →

Post navigation